Oveporexton Approved in China for Narcolepsy Type 1 in Patients Aged 16 Years and Older – Takeda
Takeda China announced that the National Medical Products Administration (NMPA) of China has approved the use of Orzeyful (oveporexton) for the treatment of narcolepsy type 1 (NT1) in… read more.
